Monoclonal Gammopathy of Renal Significance (MGRS): The Ultimate Nephrology Board Review

Learn how small monoclonal B-cell or plasma-cell clones can cause significant kidney damage—even without meeting criteria for multiple myeloma or lymphoma. 📚 Topics Covered Pathophysiology: How monoclonal immunoglobulins cause kidney injury. Clinical Presentation: Proteinuria, hematuria, declining kidney function, and nephrotic syndrome. Diagnosis: Serum and urine electrophoresis with immunofixation, serum free light chains, and kidney biopsy. Kidney Pathology: AL amyloidosis, monoclonal immunoglobulin deposition disease, proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID), and light-chain cast nephropathy mimics. Treatment: Clone-directed therapy based on whether the responsible clone is plasma-cell or B-cell derived. Board Exam Pearls: Why a small clone can cause severe kidney disease and why kidney biopsy is central to diagnosis. 🎯 High-Yield Pearl: MGRS is defined by a nephrotoxic monoclonal immunoglobulin produced by a clone that does not otherwise meet criteria for treatment as a hematologic malignancy. Treatment aims to preserve kidney function by suppressing the responsible clone. 📚 Subscribe to Nephro HighYield for high-yield nephrology board reviews, kidney biopsy interpretation, and clinical pearls. ⚠️ Educational purposes only; not individualized medical advice. #MGRS #MonoclonalGammopathy #NephroHighYield #NephrologyBoardReview #ABIM #KidneyBiopsy #PlasmaCellDisorders #GlomerularDisease #MedicalEducation